Barrett Business Services Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed strong 2025 results, with growth in billings, earnings, and client retention. All board proposals passed, including director elections and incentive plan expansion. Strategic investments in technology and market expansion are set to continue in 2026.
-
Q1 2026 results met expectations with 3.5% gross billings growth and strong client retention, despite staffing declines and macroeconomic headwinds. New tech products and benefits offerings supported growth, while capital returns to shareholders continued.
Fiscal Year 2025
-
Full-year results exceeded earnings guidance with strong WSE growth and high client retention, despite Q4 revenue slightly missing forecasts due to macro headwinds. 2026 outlook is cautious but expects continued controllable growth, with ongoing investments in technology and capital returns to shareholders.
-
Record Worksite employee growth and 8.6% revenue increase were driven by new client adds, product expansion, and high retention. Asset light markets and benefits products saw strong momentum, while macro uncertainty in California and rising insurance rates impacted some segments.
-
Q2 2025 saw 10.1% revenue growth, record new client additions, and strong margin performance. Full-year guidance was raised, with continued investments in technology and new markets, and a new $100M buyback program was approved.
-
Record Q1 with 9.5% gross billings growth, strong new client adds, and robust PEO performance. Outlook maintained due to macro uncertainty, with continued investment in products and expansion. Net loss per share reflects typical Q1 seasonality.
Fiscal Year 2024
-
Q4 and full-year results exceeded expectations with record WSE adds, strong client retention, and robust gross billings growth. Investments in technology and benefits drove expansion, while 2025 guidance anticipates continued growth and stable margins.
-
Q3 saw 9% gross billings growth, record worksite employee additions, and strong client retention. Full-year guidance was raised, with continued expansion of health benefits and new products planned for 2025. Cash position remains strong, with significant capital returned to shareholders.
-
Q2 results showed 6% gross billings growth, record WSE additions, and strong client retention. Favorable workers' comp adjustments and a new Kaiser health partnership boosted performance, while guidance for 2024 remains positive with 6–8% billings growth expected.